Alternative Splicing Generates a Nuclear ACSS2 Isoform that Regulates Cardiomyocyte Contractile Gene Programs

Imagine your body as a bustling city where every building needs power to stay lit and functional. In the heart, the "buildings" are muscle cells called cardiomyocytes, and they work overtime, beating billions of times without a break. To keep this city running, these cells need a special kind of fuel called acetyl-CoA. Think of acetyl-CoA as a versatile utility token: it can be used to build new parts for the city (like making fat for energy storage) or, more importantly for the heart, it can be used to flip switches on the DNA inside the cell's control center (the nucleus). These switches, known as histone acetylation, tell the cell's genes when to turn on and start building the machinery needed for the heart to squeeze and pump. For a long time, scientists knew that a protein called ACSS2 helps make this utility token, but they thought it mostly worked in the cell's "factory floor" (the cytoplasm) to build fats. They didn't realize that in heart cells, this protein might have a secret second job as a master switch-operator right inside the control center.

This paper tells the story of how scientists discovered that heart cells have a special, custom-made version of the ACSS2 protein. While most cells in the body use a standard, shorter version of this protein, heart cells (and skeletal muscle cells) have a unique "long" version. It's like heart cells are wearing a special uniform with an extra pocket that changes how the protein behaves. The researchers found that this extra pocket acts like a magnetic key, constantly pulling the protein into the cell's nucleus. Once inside, this "long" ACSS2 doesn't just hang out; it sits right on the DNA switches that control the heart's ability to contract. The study suggests that without this special long version, the heart loses its ability to fine-tune these genetic switches, especially when the heart is under stress, leading to a weaker pump and a heart that struggles to adapt to heavy workloads.

The Heart's Secret Switch-Operator

The story begins with a simple observation: the heart is a high-performance engine that never stops. It needs a constant supply of energy, but it also needs a way to constantly repair and rebuild its own parts, like the tiny fibers (sarcomeres) that do the actual squeezing. Scientists knew that a molecule called acetyl-CoA is the key to this repair process because it helps "tag" the DNA to keep these repair genes turned on. The enzyme ACSS2 is responsible for making acetyl-CoA from acetate, a common fuel source. However, there was a mystery: in most tissues, ACSS2 lives in the cytoplasm, the jelly-like fluid outside the nucleus. But in the heart, something seemed different.

The researchers, led by a team at Humanitas University, decided to investigate the genetic blueprints of ACSS2. They found that while most tissues use a standard, short version of the gene, heart cells and skeletal muscle cells have a secret weapon: a long version called ACSS2-L. This long version is created by a process called "alternative splicing," which is like a genetic editor that decides to keep an extra page in the instruction manual. This extra page adds a tiny strip of 13 amino acids to the protein.

Why does this tiny strip matter? The team discovered that this extra strip acts like a structural change that flips a switch. In the standard short version, the "nuclear localization signal" (NLS)—which is basically a "get me to the nucleus" address label—is hidden or folded away, making it hard for the cell's transport trucks (importins) to grab it. But in the long version, that extra strip of 13 amino acids acts like a wedge, prying the protein open and exposing the address label. This makes the long version much easier for the cell to grab and drag straight into the nucleus. In fact, the researchers found that in heart cells, this long version is the predominant transcript, and it lives almost exclusively in the nucleus, unlike its short cousin which hangs out in the cytoplasm. While the short version is found in other tissues like the brain, and the long version is also present in skeletal muscle, mature cardiomyocytes selectively express this long isoform, whereas other heart cells like fibroblasts primarily use the short version.

The Master of the Genetic Switches

Once inside the nucleus, what does this long ACSS2 do? The researchers used a technique called ChIP-seq to map exactly where the protein sits on the DNA. They found that ACSS2-L doesn't just wander around; it parks itself right on the "active" switches (promoters and enhancers) of genes that are crucial for the heart's job. Specifically, it loves to hang out near the genes that build the sarcomere—the contractile machinery that makes the heart beat. These include genes for myosin, actin, and troponin, the heavy lifters of the heart muscle.

To see what happens when you take this protein away, the team created mice that lacked ACSS2-L in their heart cells. They didn't just see a small change; they saw a breakdown in the heart's genetic programming. When the protein was gone, the "tags" (H3K27ac) that keep the contractile genes turned on started to disappear from the right spots. The result? The heart cells stopped making enough of the proteins needed to squeeze effectively.

The team tested this by measuring how well the heart cells could contract. The cells without ACSS2-L were weaker. They didn't shorten as much, and they were slower to relax. Interestingly, the cells tried to compensate by letting in more calcium (the chemical signal that triggers a beat), but it wasn't enough to fix the weakness. It was as if the engine was revving up but the pistons were too weak to push the car forward. Under normal, resting conditions, the mice without the protein showed only a mild phenotype, but their hearts were primed to struggle when challenged.

Stress Test: When the Heart is Pushed

The real test came when the researchers stressed the heart. They subjected the mice to a surgery called Transverse Aortic Constriction (TAC), which mimics high blood pressure by narrowing the main artery. A healthy heart responds to this stress by getting thicker and stronger (concentric hypertrophy) to push harder against the resistance.

The mice with the long ACSS2-L protein did exactly that; their hearts got thicker and adapted well. But the mice without it? They failed to mount this adaptive response. Instead of getting stronger, their hearts got thin and stretched out (eccentric remodeling). This is a dangerous path that often leads to heart failure. The heart dilated, the walls got too thin, and the pumping function dropped. This suggests that ACSS2-L is essential for the heart to know how to respond to stress. Without it, the heart's genetic program for "getting strong" fails, and it starts to break down.

A Human Connection

Is this just a mouse story, or does it matter for humans? The researchers checked human cells grown in a lab (derived from stem cells) and found the same thing: human heart cells also produce this long version of ACSS2, and it lives in the nucleus. They even looked at genetic data from thousands of people and found that variations in the ACSS2 gene are linked to how well the heart pumps (ejection fraction). People with genetic variants that lead to higher ACSS2 expression tended to have better heart function. This confirms that the mechanism discovered in mice is likely at work in us, too.

The Big Picture

So, what's the takeaway? The heart isn't just a pump; it's a smart, adaptable machine that constantly rewrites its own instruction manual to stay strong. This paper reveals that a specific, long version of the ACSS2 protein is the editor that keeps those instructions clear. By living in the nucleus and directly tagging the DNA, ACSS2-L ensures that the heart keeps building the muscle fibers it needs to beat. When this editor is missing, the heart loses its ability to adapt to stress, leading to a weaker pump and a higher risk of failure. It's a beautiful example of how a tiny change in a protein's structure can have a massive impact on the health of our most vital organ.